Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s BMY Position: Q2 2026 in Review
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) increased its Bristol-Myers Squibb (BMY) stake by 50% in Q2 2026, buying an estimated $201K and bringing the position to 10,500 shares worth $605K. The position accounts for 0.24% of the portfolio, ranked #101.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. 2,006 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 10,500 shares of Bristol-Myers Squibb worth $605K as of Q2 2026.
- Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) bought 3,500 Bristol-Myers Squibb shares in Q2 2026, an estimated $201K.
- Bristol-Myers Squibb made up 0.24% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #101 holding.
- Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
- 2,006 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.